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SUMMARY – In patients with atherosclerotic stenosis of the extracranial segment of internal 
carotid artery, surgical intervention is an eff ective method to prevent cerebral ischemic stroke. How-
ever, this surgical procedure may cause vascular brain damage. Th e aim of the study was to investigate 
consequential brain ischemia-reperfusion injury by measuring the cerebral specifi c marker, neuron-
specifi c enolase (NSE), in serum of patients having undergone internal carotid endarterectomy (CEA). 
Th e study involved 25 patients that underwent CEA due to internal carotid artery stenosis. Blood 
samples were obtained from each patient on three occasions: within 24 h prior to surgery, 12 h after 
surgery, and 48 h after surgery. Serum NSE levels were measured by a commercially available enzyme-
linked immunosorbent assay. Th e study showed that serum NSE level was statistically signifi cantly 
increased 48 h after CEA as compared with the level 12 h after surgery and the level before surgery 
(p<0.05). Diff erence in serum NSE between the level before surgery and 12 h after CEA was not 
statistically signifi cant (p>0.05). Data from our study showed CEA to aff ect serum NSE in patients 
with signifi cant internal carotid artery stenosis. Th us, serum NSE may be used as a biochemical mark-
er of brain ischemia-reperfusion injury following CEA.
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Introduction
Stroke including ischemic stroke is one of the ma-
jor public health problems worldwide, particularly in 
industrialized countries. Strokes are a frequent cause 
of acute hospitalization, severe morbidity, and the 
third cause of overall mortality1.
Surgical treatment of atherosclerotic stenosis of the 
extracranial segment of internal carotid artery is an ef-
fective method of preventing cerebral ischemic stroke2. 
However, it should be noted that the procedure is bur-
dened with the consequences of neurological compli-
cations during the perioperative period. Microembo-
lisms, macroembolisms, and increased or decreased 
blood fl ow to the brain as a result of internal carotid 
artery endarterectomy (CEA) may lead to ischemic 
and/or hyperperfusion brain damage3-5.
Neuron-specifi c enolase (NSE) is a dimeric isoen-
zyme of the glycolytic enzyme enolase. NSE has a mo-
lecular weight of approximately 80 kDa and is found 
mainly in the neurons and cells of the neuroendocrine 
system. It participates in slow axoplasmic transport. 
NSE is not normally secreted, but when axons are 
damaged, NSE is upregulated to maintain homeosta-
sis. Th erefore, NSE is the only marker that directly as-
sesses functional damage to neurons. As NSE is main-
ly found in neurons, its level in serum or cerebrospinal 
fl uid (CSF) may be elevated in neurological diseases. 
According to Jauch et al., biochemical markers of acute 
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neuronal injury including NSE may play a role in the 
diagnosis and management of cerebral ischemia. Th e 
authors observed increased 24-h peak levels of NSE 
that were associated with higher than normal baseline 
scores set forth by the National Institutes of Health 
Stroke Scale. Moreover, serum NSE may have a prog-
nostic value in traumatic brain injury. Unfavorable 
outcomes and mortality of patients were signifi cantly 
associated with increased serum NSE levels. It is also 
concluded that NSE has a moderate discriminatory 
ability to predict mortality and neurological outcome 
in patients with traumatic brain injury6,7.
Th erefore, NSE may also be a biochemical marker 
of brain ischemia-reperfusion injury in patients under-
going CEA. Th e aim of the study was to investigate 
serum NSE levels and its changes over time in these 
patients.
Patients and Methods
Th e study involved patients hospitalized in the De-
partment of Vascular Surgery and Angiology, Medical 
University of Lublin, Lublin, Poland, undergoing 
CEA due to internal carotid artery stenosis. Patients 
were qualifi ed for surgical treatment according to the 
guidelines of the European Society of Vascular Sur-
gery based on Doppler studies performed using a 
Toshiba Aplio 500 ultrasound8. Patients with high 
grade stenotic carotid arteries were identifi ed and 
measured by using the guidelines set by the North 
American Symptomatic Carotid Endarterectomy Tri-
al (NASCET)9.
Th e study group consisted of 25 participants (15 
male and 10 female) aged from 54 to 88 years, average 
69 years. Patients with occlusion of the internal carotid 
artery were not qualifi ed for surgery and research. Th e 
degree of internal carotid artery stenosis ranged from 
60% to 90%. Th e average clamping time of internal 
carotid artery during CEA was 8.5 minutes. Conven-
tional CEA was performed under local anesthesia. 
Shunt was not used. No complications associated with 
CEA were observed. Th e mean velocity of blood fl ow 
in the internal carotid artery was 208.4 cm/s (blood 
fl ow 1) before surgery and 89.5 cm/s (blood fl ow 2) 
after surgery. Past medical histories of study subjects 
included previous ischemic stroke (n=8), transient 
ischemic attack (n=7), and asymptomatic internal ca-
rotid artery stenosis (n=10). Th e study criteria disqual-
ifi ed patients with known organic brain damage in the 
course of various diseases of the nervous system (e.g., 
multiple sclerosis, Alzheimer’s disease).
Blood samples were obtained from each patient 
from the antecubital vein on three occasions: within 24 
h prior to surgery (NSE 1), 12 h after surgery (NSE 2), 
and 48 h after surgery (NSE 3). Serum samples were 
collected into plastic tubes, centrifuged rapidly, and 
stored at -80 ˚C until analysis. Serum NSE levels were 
measured by a commercially available enzyme-linked 
immunosorbent assay (Enzyme-Linked Immunosor-
bent Assay Kit for Enolase, Neuron Specifi c (NSE), 
Cloud Clone Corp./USCN, Houston, TX, USA).
Statistical analysis was performed using STATIS-
TICA version 10 software (StatSoft, Inc., Poland). 
Distribution of the collected data was evaluated using 
the Shapiro-Wilk’s test. Furthermore, data on the 
NSE levels were analyzed using ANOVA with post hoc 
Tukey HSD test. For the dichotomous system, Stu-
dent’s t-test and Mann-Whitney U test (depending on 
the distribution obtained) were used to examine be-
tween-group diff erences. Correlation analysis was per-
formed using the Spearman rank correlation. Th e NSE 
values were expressed in ng/mL. Th e values of p<0.05 
were considered signifi cant.
Th e study was approved by the Ethics Committee 
of Medical University in Lublin (KE-0254/218/2014).
Results
Th e ANOVA test showed that sampling time sig-
nifi cantly aff ected serum NSE levels (p<0.05). Serum 
NSE levels and comparative analysis are presented in 
Table 1.
Th e post hoc Tukey HSD test revealed that serum 
NSE level was statistically signifi cantly increased 48 h 
after CEA as compared with the levels measured 12 h 
after surgery and prior to surgery (p<0.05). However, 
diff erence in serum NSE levels prior to surgery and 12 
h after CEA was not statistically signifi cant (p>0.05) 
(Table 2).
Th ere was no statistically signifi cant diff erence in 
serum NSE levels between symptomatic and asymp-
tomatic patients (p>0.05). Th ere was no statistically 
signifi cant correlation between serum NSE levels and 
clamping time either (p>0.05).
Th ere was no statistically signifi cant correlation of 
serum NSE levels with blood fl ow velocity in internal 
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Mean SD Median Min Max
NSE 1 25 1.34 0.38 1.29 0.43 2.14
<0.001*NSE 2 25 1.59 0.43 1.53 0.98 2.52
NSE 3 25 2.00 0.95 1.82 0.31 4.09
ANOVA test; *statistically signifi cant
Table 2. Comparative analysis of neuron-specifi c enolase 
(NSE) levels in patient sera
Diff erence Signifi cance
NSE 1 – NSE 2 p=0.2764
NSE 2 – NSE 3  p=0.0338*
NSE 1 – NSE 3  p=0.0005*
Post hoc Tukey HSD test; *statistically signifi cant
Table 3. Correlation of serum neuron-specifi c enolase 
(NSE) levels with blood fl ow velocity in internal carotid 
artery
Correlation r Signifi cance
NSE 1 & blood fl ow 1 -0.11 p=0.6069
NSE 2 & blood fl ow 1 -0.15 p=0.4646
NSE 3 & blood fl ow 1 -0.12 p=0.5624
NSE 1 & blood fl ow 2 0.11 p=0.5941
NSE 2 & blood fl ow 2 0.16 p=0.4422
NSE 3 & blood fl ow 2 0.28 p=0.1693
Fig. 1. Correlation between neuron-specifi c enolase (NSE) NSE 2/NSE 3 levels and blood fl ow velocity 
in internal carotid artery.
carotid artery before CEA and after surgery (p>0.05) 
(Table 3).
However, change in the blood fl ow calculated as: 
[(blood fl ow rate after surgery – blood fl ow rate prior 
to surgery)/blood fl ow rate prior to surgery]*100 and 
change in the NSE2 and NSE3 levels indicated statis-
tically signifi cant correlations (r=0.45, p=0.0239; and 
r=0.41, p=0.0394, respectively). Th e correlation be-
tween NSE2/NSE3 levels and blood fl ow velocity in 
internal carotid artery is illustrated in Figure 1.
Discussion
Our study revealed that serum NSE level was sta-
tistically signifi cantly increased 48 h after CEA as 
compared with the levels 12 h after surgery and prior 
to surgery. Dragas et al.10 observed that changes in se-
rum NSE occurred after CEA. Th e authors concluded 
that serum NSE could be used as a potential marker of 
brain injury after surgery. Capoccia et al.11 investigated 
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the relationship between serum levels of two biochem-
ical markers of cerebral injury, S100 protein and NSE, 
using postoperative diff usion-weighted magnetic reso-
nance imaging, and neuropsychometric testing in pa-
tients undergoing CEA or carotid artery stenting 
(CAS). Th e authors observed that the aforementioned 
biochemical markers were signifi cantly increased at 24 
h in CAS patients as compared with CEA patients. 
According to the authors, the increased S100 and NSE 
levels following CAS may be caused by perioperative 
microembolization rather than hypoperfusion. Bright-
well et al.12 measured serum S-100b and NSE levels in 
patients undergoing CEA and CAS, and found associ-
ated hemodynamic and embolic events detected using 
transcranial Doppler (TCD). TCD fi ndings showed 
that the mechanisms of these increased biochemical 
markers may have diff ered, and thus may have been 
caused by microembolization and cerebral hypoperfu-
sion, respectively. According to the authors, cerebral 
hypoperfusion is responsible for the increase of the 
above mentioned brain damage markers in cases re-
lated to CEA.
Serum levels of NSE were measured intraopera-
tively, prior to and after carotid clamping. Th ere was no 
diff erence in subtle cerebral damage between patients 
randomized to receive a shunt or not13. Gao et al.14 
studied NSE levels in serum of patients before, during, 
and for 2 days after CEA performed under general an-
esthesia and incorporating the use of a Javid shunt. 
Serum NSE level increased during shunting, while the 
CSF NSE level did not change.
Diff erent results were obtained in studies conduct-
ed by Rasmussen et al.15. Th e authors measured serum 
levels of NSE in patients before CEA and postopera-
tively at 12, 24, 36 and 48 h. Compared with abdomi-
nal aortic surgery patients, the preoperative serum 
level of NSE was signifi cantly higher in carotid artery 
surgery patients. Postoperatively, serum NSE level de-
creased signifi cantly after uncomplicated CEA, and 
the level was then similar to that in the aortic surgery 
patients. Th e authors concluded that subtle brain dam-
age after carotid artery surgery could not be detected 
by measuring blood levels of NSE.
Th e mechanism of serum NSE elevation observed 
in our study is unknown, but we support the hypoth-
esis that increased blood-brain barrier permeability 
caused by hypoxia during carotid cross-clamping may 
infl uence NSE leaking from the brain into the blood. 
Cerebral damage during carotid clamping may be the 
result of microembolism and/or hypoperfusion. Ele-
vated serum NSE levels may refl ect ischemia-induced 
enzyme loss. An increase in serum NSE level may also 
be caused by hyperperfusion brain damage during 
CEA. In many patients, clamping of the internal ca-
rotid artery during CEA results in transient decrease 
in cerebral blood fl ow in the ipsilateral cerebral hemi-
sphere16. If this decrease in the hemispheric cerebral 
blood fl ow is signifi cant enough to impair autoregula-
tion, then consequently ipsilateral cerebral hyperper-
fusion can occur after internal carotid artery declamp-
ing. Development of cerebral hyperperfusion after 
CEA is associated with preoperative hemodynamic 
impairment and intraoperative cerebral ischemia17. It 
has been suggested that acute ischemia and reperfu-
sion by clamping and declamping of the internal ca-
rotid artery may produce oxygen-derived free radicals 
resulting in impairment of cerebrovascular autoregula-
tion, postischemic hyperperfusion, or/and brain ede-
ma18,19.
Brouns et al.20 investigated CSF levels of diff erent 
neuromarkers including NSE in acute ischemic stroke 
patients and their relation to initial stroke severity, 
stroke location, and long-term stroke outcome. Th ey 
concluded that biomarkers displayed relevant diff er-
ences in cellular and subcellular origins, which were 
refl ected in their relation to stroke characteristics.
In conclusion, data from our study showed that 
CEA aff ected serum NSE in patients with signifi cant 
internal carotid artery stenosis. Th us, serum NSE may 
be used as a biochemical marker of brain ischemia-re-
perfusion injury after CEA.
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Sažetak
SERUMSKA RAZINA ZA NEURON SPECIFIČNE ENOLAZE 
KAO BILJEG ISHEMIJSKO-REPERFUZIJSKOG OŠTEĆENJA 
U BOLESNIKA PODVRGNUTIH KAROTIDNOJ ENDARTEREKTOMIJI
M. Iłżecki, J. Iłżecka, S. Przywara, P. Terlecki, A. Grabarska, A. Stepulak i T. Zubilewicz
Kirurška intervencija je učinkovita metoda sprječavanja ishemijskog moždanog udara u bolesnika s aterosklerotskom 
stenozom ekstrakranijskog dijela unutarnje karotidne arterije. Međutim, ovaj kirurški zahvat može uzrokovati oštećenje 
moždanog krvožilja. Cilj ovoga istraživanja bio je ispitati posljedično ishemijsko-reperfuzijsko oštećenje mozga mjerenjem 
za neuron specifi čne enolaze (neuron-specifi c enolase, NSE) kao specifi čnog moždanog biljega u serumu bolesnika podvrgnu-
tih endarterektomiji unutarnje karotide (internal carotid endarterectomy, CEA). Istraživanje je obuhvatilo 25 bolesnika 
 podvrgnutih CEA zbog stenoze unutarnje karotidne arterije. Uzorci krvi uzeti su u svakog bolesnika tri puta: unutar 24 h 
prije operacije, 12 h nakon operacije i 48 h nakon operacije. Serumske razine NSE mjerene su komercijalnim testom ELISA. 
Rezultati su pokazali da je serumska razina NSE bila statistički značajno povišena 48 h nakon CEA u usporedbi s razinom 
izmjerenom 12 h nakon operacije, kao i u usporedbi s razinom prije operacije (p<0,05). Razlika u serumskoj razini NSE 
prije operacije i 12 h nakon CEA nije bila statistički značajna (p>0,05). Podaci dobiveni u ovom istraživanju pokazuju da 
CEA utječe na razinu NSE u serumu kod bolesnika sa značajnom stenozom unutarnje karotidne arterije. Stoga bi serumska 
razina NSE mogla poslužiti kao biokemijski biljeg ishemijsko-reperfuzijskog oštećenja mozga nakon CEA.
Ključne riječi: Endarterektomija karotide; Ishemijski moždani udar; Enolaza specifi čna za neuron
